Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

被引:0
作者
Jos A van der Hage
J Sven D Mieog
Marc J van de Vijver
Cornelis JH van de Velde
机构
[1] Department of Surgery,Leiden University Medical Center
[2] European Organization for Research and Treatment of Cancer Data Center,The Netherlands Cancer Institute
[3] Department of Pathology,undefined
来源
Breast Cancer Research | / 9卷
关键词
Tamoxifen; Estrogen Receptor Status; Premenopausal Patient; LHRH Agonist; Adjuvant Systemic Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 136 条
  • [1] Hankey BF(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717
  • [2] Miller B(1994)Trends in breast cancer in younger women in contrast to older women J Natl Cancer Inst Monogr 16 7-14
  • [3] Curtis R(2001)Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer J Clin Oncol 19 3817-3827
  • [4] Kosary C(2000)High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study J Clin Oncol 18 1075-1083
  • [5] Goldhirsch A(2000)Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355L 1869-1874
  • [6] Glick JH(2000)Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial J Natl Cancer Inst 92 1143-1150
  • [7] Gelber RD(2001)Improved survival after one course of perioperative chemotherapy in early breast cancer patients: long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854 Eur J Cancer 37 2184-2193
  • [8] Coates AS(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902 J Clin Oncol 19 4224-4237
  • [9] Senn HJ(2001)European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation N Engl J Med 345 1378-1387
  • [10] Elkhuizen PH(1957)Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years Br J Cancer 11 359-377